Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiltronic Regulatory News (FTC)

Share Price Information for Filtronic (FTC)

Share Price is delayed by 15 minutes
Get Live Data
330.00    15.00 (4.76%)
Bid:
325.00
Ask:
335.00
Spread: 10.00 (3.077%)
Market Cap: £725.81m
FTC Live PriceLast checked at - London Stock Exchange

Intraday Filtronic Share Chart

Grant of Options

28 May 2024 10:20

RNS Number : 0967Q
Filtronic PLC
28 May 2024
Β 

28 May 2024

Β 

Filtronic plc

Β ("Company")

Β 

Grant of Options

Β 

Filtronic plc (AIM: FTC), the designer and manufacturer of products for theΒ aerospace, defence, telecoms infrastructure, space and critical communications markets, announces that on 24 May 2024, the Board, following the recommendation from the Remuneration Committee, granted new share options ("the Options") to the following director under the existing Filtronic plc Employee Share Option Plan 2020 ("the ESOP"). The Options were a key component of the offer package to attract Mr Edington to join the Company.

Β 

The vesting of these options is based on achieving certain performance criteria in the three years prior to vesting. The performance criteria under the ESOP are based on share price growth and adjusted earnings before interest, taxation, depreciation, amortisation and exceptional items ("adjusted EBITDA"), in the three-year vesting period. The Options will fully vest if the share price grows by 2.25 times the share price on the date immediately prior to grant which was 55.12p and will start vesting if the share price has grown by over 1.5 times at the vesting date. The exercise price for the Options is 17.25 pence per share being the same exercise price as the options granted to the scheme participants on 30 November 2023. The Options lapse on the tenth anniversary of the date of grant and no option can be exercised before the third year of the date of grant.

Β 

Director/PDMR

Options prior to Grant

Options granted

Resultant ESOP holdings

Nat Edington

Chief Executive Officer

Β 

0

4,333,333

4,333,333

Β 

The Remuneration Committee keeps the ESOP scheme under regular review with the timing of grant award varying dependent on previous issue of share options to directors and employees.

Β 

Enquiries:

Filtronic plc

Tel. 01740 618800 or investor.relations@filtronic.com

Nat Edington (Chief Executive Officer)

Β 

Michael Tyerman (Chief Financial Officer)

Β 

Β 

Cavendish Capital Markets Limited

Tel. 020 7220 0500

Jonny Franklin-Adams/George Dollemore (Corporate Finance)

Sunila de Silva (ECM)

Β 

Β 

Walbrook PR Limited

Tel. 020 7933 8780 or filtronic@walbrookpr.com

Nick Rome

Mob. 07768 807 631

Β 

Β 

Β 

Further details of the PDMR dealing are included below. This information has been provided in accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nat Edington

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

Β 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Filtronic plc

b)

LEI

213800PDQ9V2ZNCDO264

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Β 

Ordinary shares of 0.1p each

Β 

Identification code

GB0003362992

b)

Nature of the transaction

Grant of 1,370,012 options under the Filtronic plc Employee Share Option Plan 2020

c)

Price(s) and volume(s)

Price(s)

Volume(s)

17.25 pence

4,333,333

Β 

d)

Aggregated information:

Β· Aggregated volume

Β· Price

Β 

n/a (single transaction)

e)

Date of the transaction

24 May 2024

f)

Place of the transaction

London Stock Exchange, AIM Market

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEANSPAFPLEEA
Date   Source Headline
5th Mar 20252:11 pmRNSHolding(s) in Company
13th Feb 20255:24 pmRNSHolding(s) in Company
10th Feb 20257:00 amRNSFurther Contract Win with SpaceX
4th Feb 20257:00 amRNSInterim Results
15th Jan 20253:01 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNS-RLeadership Team appointments
13th Jan 20257:00 amRNSTrading Ahead of Expectations
9th Jan 202511:06 amRNSHolding(s) in Company
6th Jan 20257:00 amRNS-RAppointment of Chief Commercial Officer
16th Dec 20247:00 amRNSTrading Update
25th Nov 20246:00 pmRNSHolding(s) in Company
31st Oct 20244:57 pmRNSResult of AGM
31st Oct 20247:00 amRNSAGM Trading Update & Notice of Results
18th Oct 202410:16 amRNSHolding(s) in Company
7th Oct 20243:26 pmRNSExercise of Options and Total Voting Rights
3rd Oct 202412:40 pmRNSDirector/PDMR Dealing
26th Sep 20241:00 pmRNSNotice of AGM & Posting of Annual Report
16th Sep 20245:30 pmRNSHolding(s) in Company
3rd Sep 20243:31 pmRNSExercise of Options, Director Dealing and TVR
30th Aug 20247:00 amRNSContract Win
5th Aug 20247:00 amRNSIssue of Equity
30th Jul 20247:00 amRNSFinal Results
23rd Jul 20247:00 amRNSContract Win
9th Jul 20244:33 pmRNSHolding(s) in Company
1st Jul 202410:19 amRNSIssue of Equity
26th Jun 20249:00 amRNSExercise of Options, Director Dealing and TVR
20th Jun 20249:58 amRNSHolding(s) in Company
20th Jun 20247:00 amRNSTrading Update & Notice of Final Results
4th Jun 20244:51 pmRNSIssue of Equity
28th May 202410:20 amRNSGrant of Options
24th May 20248:41 amRNSHolding(s) in Company
13th May 20244:24 pmRNSHolding(s) in Company
8th May 20247:00 amRNSFiltronic awarded King’s Award for Innovation
3rd May 20241:22 pmRNSHolding(s) in Company
1st May 20244:33 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSTrading Update
24th Apr 20247:00 amRNSStrategic Agreement with SpaceX
9th Apr 20242:30 pmRNSHolding(s) in Company
2nd Apr 20247:00 amRNSDirectorate Change
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
12th Mar 20241:37 pmRNSExercise of Options and Total Voting Rights
13th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20245:47 pmRNSExercise of Options, Director Dealing and TVR
8th Feb 20248:19 amRNSHolding(s) in Company
6th Feb 20247:00 amRNSInterim Results
6th Feb 20247:00 amRNSNew £7.8m Contract Award
16th Jan 20244:28 pmRNSHolding(s) in Company
15th Jan 20247:00 amRNSContract win with QinetiQ for Defence Radar
20th Dec 20237:00 amRNSNew £4.8 million Contract Award
19th Dec 20237:00 amRNSNew £4.5 million Contract Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.